Vestal Point Capital, LP
Filing Date
Global Rank
#828
/ 8,700
▲ 190
Top Industry
Biotechnology
66.0%
Period ended 2 months ago
Filed Aug 14, 2026 · 30d
11 quarters · since Dec 2023
Portfolio Concentration
68 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
8.1%
+1.3 pts
Top 5
33.0%
+6.4 pts
Top 10
50.3%
+8.0 pts
HHI
365
Diversified+90
Portfolio Trend
11 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $4,279,469,232 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| MYGN | Myriad Genetics Inc | +4,087,000 | 5,735,000 | $32,746,850 | |
| BMRN | Biomarin Pharmaceutical Inc | +2,450,000 | 6,025,000 | $344,750,500 | |
| NRIX | Nurix Therapeutics, Inc. | +1,550,000 | 8,050,000 | $195,293,000 | |
| TSHA | Taysha Gene Therapies, Inc. | +1,415,000 | 19,415,000 | $132,216,150 | |
| BCRX | Biocryst Pharmaceuticals Inc | +1,275,000 | 8,300,000 | $83,000,000 | |
| ZBH | Zimmer Biomet Holdings, Inc. | +1,210,000 | 1,400,000 | $120,526,000 | |
| GLUE | Monte Rosa Therapeutics, Inc. | +996,535 | 4,600,000 | $111,320,000 | |
| TRVI | Trevi Therapeutics, Inc. | +933,496 | 3,100,000 | $57,815,000 | |
| IRON | Disc Medicine, Inc. | +850,000 | 1,550,000 | $113,367,000 | |
| TARS | Tarsus Pharmaceuticals, Inc. | +850,000 | 1,050,000 | $66,087,000 | |
| ABVX | Abivax S.A. | +849,443 | 2,349,443 | $313,086,774 | |
| ELVN | Enliven Therapeutics, Inc. | +750,000 | 4,000,000 | $203,000,000 | |
| NKTR | Nektar Therapeutics | +715,000 | 1,000,000 | $69,810,000 | |
| ZURA | Zura Bio Ltd | +662,956 | 1,173,956 | $6,926,340 | |
| NBIX | Neurocrine Biosciences Inc | +630,000 | 1,880,000 | $316,855,200 | |
| PODD | Insulet Corp | +619,399 | 670,000 | $102,007,500 | |
| SNY | Sanofi | +600,000 | 2,000,000 | $85,320,000 | |
| QURE | uniQure N.V. | +576,004 | 935,000 | $43,066,100 | |
| UTHR | UNITED THERAPEUTICS Corp | +360,000 | 435,000 | $235,696,050 | |
| AZN | Astrazeneca PLC | +350,000 | 450,000 | $85,329,000 | |
| GMED | Globus Medical Inc | +239,480 | 850,000 | $67,158,500 | |
| GEHC | GE HealthCare Technologies Inc. | +200,000 | 450,000 | $28,804,500 | |
| ZBIO | Zenas BioPharma, Inc. | +165,000 | 365,000 | $9,263,700 | |
| CBIO | Crescent Biopharma, Inc. | +130,000 | 1,630,000 | $29,340,000 | |
| SVRA | Savara Inc | +119,948 | 2,720,000 | $16,755,200 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
22 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| SLDB | Solid Biosciences Inc. | −2,840,000 | 2,160,000 | $21,578,400 | |
| RVMD | Revolution Medicines, Inc. | −1,925,000 | 450,000 | $84,276,000 | |
| ANRO | Alto Neuroscience, Inc. | −1,279,075 | 785,000 | $20,716,150 | |
| IMCR | Immunocore Holdings plc | −966,868 | 1,800,000 | $57,150,000 | |
| RAPP | Rapport Therapeutics, Inc. | −706,229 | 730,000 | $30,419,100 | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | −700,000 | 1,575,000 | $128,378,250 | |
| DYN | Dyne Therapeutics, Inc. | −625,000 | 3,375,000 | $74,958,750 | |
| BBNX | Beta Bionics, Inc. | −611,518 | 1,600,000 | $25,072,000 | |
| RGEN | Repligen Corp | −525,000 | 400,000 | $54,576,000 | |
| ENGN | enGene Therapeutics Inc. | −497,570 | 1,667,430 | $2,884,653 | |
| VYGR | Voyager Therapeutics, Inc. | −377,936 | 2,625,000 | $9,187,500 | |
| ALC | Alcon Inc | −300,000 | 500,000 | $33,550,000 | |
| VKTX | Viking Therapeutics, Inc. | −234,147 | 680,000 | $26,526,800 | |
| BMY | Bristol Myers Squibb Co | −200,000 | 800,000 | $46,096,000 | |
| BCAX | Bicara Therapeutics Inc. | −175,000 | 5,250,000 | $155,872,500 | |
| LXEO | Lexeo Therapeutics, Inc. | −155,000 | 4,320,000 | $20,109,600 | |
| AVR | Anteris Technologies Global Corp. | −134,780 | 1,010,000 | $9,948,500 | |
| SRZN | Surrozen, Inc./DE | −33,942 | 304,669 | $7,906,160 | |
| NYXH | Nyxoah SA | −25,200 | 843,461 | $1,425,449 | |
| DMRA | Damora Therapeutics, Inc. | −25,000 | 575,000 | $14,955,750 | |
| OKUR | OnKure Therapeutics, Inc. | −14,120 | 1,825,699 | $8,325,187 | |
| OLMA | Olema Pharmaceuticals, Inc. | −10,000 | 418,551 | $5,236,073 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
9 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ABT | Abbott Laboratories | 1,400,000 | $127,036,000 | |
| INSM | INSMED Inc | 250,000 | $26,655,000 | |
| TRAX | First Tracks Biotherapeutics, Inc. | 1,013,000 | $20,381,560 | |
| AVTX | Avalo Therapeutics, Inc. | 775,000 | $14,322,000 | |
| EVMN | Evommune, Inc. | 1,000,000 | $13,290,000 | |
| KLRA | Kailera Therapeutics, Inc. | 575,000 | $12,667,250 | |
| IBIO | iBio, Inc. | 2,600,000 | $4,550,000 | |
| SGMT | Sagimet Biosciences Inc. | 535,452 | $4,139,043 | |
| RZLT | Rezolute, Inc. | 382,999 | $1,991,594 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
25 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| APGE | Apogee Therapeutics, Inc. | 1,100,000 | $92,587,000 | |
| SRRK | Scholar Rock Holding Corp | 1,324,422 | $65,108,585 | |
| VERA | Vera Therapeutics, Inc. | 1,368,159 | $55,041,036 | |
| BSX | Boston Scientific Corp | 800,000 | $50,200,000 | |
| COGT | Cogent Biosciences, Inc. | 1,230,888 | $47,376,879 | |
| CLDX | Celldex Therapeutics, Inc. | 1,224,165 | $38,830,513 | |
| PTGX | Protagonist Therapeutics, Inc | 326,159 | $34,377,158 | |
| DNLI | Denali Therapeutics Inc. | 1,773,326 | $34,047,859 | |
| WAT | Waters Corp /De/ | 100,000 | $29,780,000 | |
| INSP | Inspire Medical Systems, Inc. | 539,269 | $27,815,495 | |
| CYTK | Cytokinetics Inc | 300,000 | $19,773,000 | |
| WST | West Pharmaceutical Services Inc | 75,000 | $18,798,000 | |
| WGS | GeneDx Holdings Corp. | 250,000 | $16,055,000 | |
| AGIO | Agios Pharmaceuticals, Inc. | 450,000 | $15,223,500 | |
| ARVN | Arvinas, Inc. | 905,465 | $9,597,929 | |
| MPLT | MapLight Therapeutics, Inc. | 420,000 | $8,538,600 | |
| FULC | Fulcrum Therapeutics, Inc. | 1,100,000 | $8,437,000 | |
| CADL | Candel Therapeutics, Inc. | 1,125,000 | $5,512,500 | |
| VCYT | Veracyte, Inc. | 130,687 | $4,209,428 | |
| GERN | Geron Corp | 2,540,000 | $3,784,600 | |
| NVCR | NovoCure Ltd | 250,000 | $2,725,000 | |
| URGN | UroGen Pharma Ltd. | 139,079 | $2,500,640 | |
| PASG | Passage BIO, Inc. | 305,000 | $2,394,250 | |
| TYRA | Tyra Biosciences, Inc. | 54,000 | $2,068,200 | |
| RGNX | REGENXBIO Inc. | 108,525 | $909,439 | |
| No positions match the current search. | ||||
68 tracked positions ·
$4,279,469,232 total
· as of Jun 30, 2026
Showing 1–50
of 68 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
Added | 6,025,000 | $344,750,500 | 8.06% | |
| NBIX |
Neurocrine Biosciences Inc
Healthcare
|
Added | 1,880,000 | $316,855,200 | 7.40% | |
| ABVX |
Abivax S.A.
Healthcare
|
Added | 2,349,443 | $313,086,774 | 7.32% | |
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
Added | 435,000 | $235,696,050 | 5.51% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
Added | 4,000,000 | $203,000,000 | 4.74% | |
| NRIX |
Nurix Therapeutics, Inc.
Healthcare
|
Added | 8,050,000 | $195,293,000 | 4.56% | |
| BCAX |
Bicara Therapeutics Inc.
Healthcare
|
Reduced | 5,250,000 | $155,872,500 | 3.64% | |
| TSHA |
Taysha Gene Therapies, Inc.
Healthcare
|
Added | 19,415,000 | $132,216,150 | 3.09% | |
| ARWR |
Arrowhead Pharmaceuticals, Inc.
Healthcare
|
Reduced | 1,575,000 | $128,378,250 | 3.00% | |
| ABT |
Abbott Laboratories
Healthcare
|
NEW | 1,400,000 | $127,036,000 | 2.97% | |
| ZBH |
Zimmer Biomet Holdings, Inc.
Healthcare
|
Added | 1,400,000 | $120,526,000 | 2.82% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
Added | 1,550,000 | $113,367,000 | 2.65% | |
| GLUE |
Monte Rosa Therapeutics, Inc.
Healthcare
|
Added | 4,600,000 | $111,320,000 | 2.60% | |
| PODD |
Insulet Corp
Healthcare
|
Added | 670,000 | $102,007,500 | 2.38% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
Held | 375,000 | $100,020,000 | 2.34% | |
| AZN |
Astrazeneca PLC
Healthcare
|
Added | 450,000 | $85,329,000 | 1.99% | |
| SNY |
Sanofi
Healthcare
|
Added | 2,000,000 | $85,320,000 | 1.99% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Reduced | 450,000 | $84,276,000 | 1.97% | |
| BCRX |
Biocryst Pharmaceuticals Inc
Healthcare
|
Added | 8,300,000 | $83,000,000 | 1.94% | |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
Reduced | 3,375,000 | $74,958,750 | 1.75% | |
| NKTR |
Nektar Therapeutics
Healthcare
|
Added | 1,000,000 | $69,810,000 | 1.63% | |
| GMED |
Globus Medical Inc
Healthcare
|
Added | 850,000 | $67,158,500 | 1.57% | |
| TARS |
Tarsus Pharmaceuticals, Inc.
Healthcare
|
Added | 1,050,000 | $66,087,000 | 1.54% | |
| IMTX |
Immatics N.V.
Healthcare
|
Held | 6,175,000 | $62,552,750 | 1.46% | |
| TRVI |
Trevi Therapeutics, Inc.
Healthcare
|
Added | 3,100,000 | $57,815,000 | 1.35% | |
| IMCR |
Immunocore Holdings plc
Healthcare
|
Reduced | 1,800,000 | $57,150,000 | 1.34% | |
| RGEN |
Repligen Corp
Healthcare
|
Reduced | 400,000 | $54,576,000 | 1.28% | |
| BMY |
Bristol Myers Squibb Co
Healthcare
|
Reduced | 800,000 | $46,096,000 | 1.08% | |
| QURE |
uniQure N.V.
Healthcare
|
Added | 935,000 | $43,066,100 | 1.01% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Added | 700,000 | $42,252,000 | 0.99% | |
| DRUG |
Bright Minds Biosciences Inc.
Healthcare
|
Added | 545,000 | $38,259,000 | 0.89% | |
| MDGL |
Madrigal Pharmaceuticals, Inc.
Healthcare
|
Added | 65,000 | $34,901,750 | 0.82% | |
| ALC |
Alcon Inc
Healthcare
|
Reduced | 500,000 | $33,550,000 | 0.78% | |
| MYGN |
Myriad Genetics Inc
Healthcare
|
Added | 5,735,000 | $32,746,850 | 0.77% | |
| RAPP |
Rapport Therapeutics, Inc.
Healthcare
|
Reduced | 730,000 | $30,419,100 | 0.71% | |
| CBIO |
Crescent Biopharma, Inc.
Healthcare
|
Added | 1,630,000 | $29,340,000 | 0.69% | |
| GEHC |
GE HealthCare Technologies Inc.
Healthcare
|
Added | 450,000 | $28,804,500 | 0.67% | |
| INSM |
INSMED Inc
Healthcare
|
NEW | 250,000 | $26,655,000 | 0.62% | |
| VKTX |
Viking Therapeutics, Inc.
Healthcare
|
Reduced | 680,000 | $26,526,800 | 0.62% | |
| BBNX |
Beta Bionics, Inc.
Healthcare
|
Reduced | 1,600,000 | $25,072,000 | 0.59% | |
| REGN |
Regeneron Pharmaceuticals, Inc.
Healthcare
|
Held | 40,000 | $24,941,600 | 0.58% | |
| SLDB |
Solid Biosciences Inc.
Healthcare
|
Reduced | 2,160,000 | $21,578,400 | 0.50% | |
| ANRO |
Alto Neuroscience, Inc.
Healthcare
|
Reduced | 785,000 | $20,716,150 | 0.48% | |
| TRAX |
First Tracks Biotherapeutics, Inc.
Healthcare
|
NEW | 1,013,000 | $20,381,560 | 0.48% | |
| LXEO |
Lexeo Therapeutics, Inc.
Healthcare
|
Reduced | 4,320,000 | $20,109,600 | 0.47% | |
| SVRA |
Savara Inc
Healthcare
|
Added | 2,720,000 | $16,755,200 | 0.39% | |
| DMRA |
Damora Therapeutics, Inc.
Healthcare
|
Reduced | 575,000 | $14,955,750 | 0.35% | |
| SGP |
SpyGlass Pharma, Inc.
Healthcare
|
Added | 670,000 | $14,914,200 | 0.35% | |
| TECX |
Tectonic Therapeutic, Inc.
Healthcare
|
Added | 425,000 | $14,611,500 | 0.34% | |
| AVTX |
Avalo Therapeutics, Inc.
Healthcare
|
NEW | 775,000 | $14,322,000 | 0.33% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.